|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | University of Texas Southwestern Medical Center |
|---|---|
| Collaborators: |
Dallas VA Medical Center National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
| Information provided by: | University of Texas Southwestern Medical Center |
| ClinicalTrials.gov Identifier: | NCT00744588 |
Purpose
This proposal is part of the INIA Stress Consortium. This study will
| Condition |
|---|
|
Alcohol Dependence |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Cross-Sectional |
| Official Title: | Stress, HPA Dysfunction, and Relapse in Alcoholism |
serum plasma whole blood urine
| Estimated Enrollment: | 100 |
| Study Start Date: | August 2007 |
| Estimated Study Completion Date: | June 2012 |
| Estimated Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
alcohol dependence
Alcohol-dependent subjects currently being treated in an inpatient treatment facility.
|
The hypothalamic-pituitary-adrenal (HPA) system is suggested as a key biologic link in stress-induced relapse. The HPA axis provides a regulatory feedback network between the brain and the body's behavioral and physiologic responses to stress, recovery, and adaptation. Both trauma and chronic alcohol use produce persistent disturbances in the HPA response to stress. The chronic use of alcohol may also impair the stress-induced release of neurosteroids, compounds that directly modulate central nervous system activity. Thus, altered cortisol and neurosteroid responsiveness during abstinence may impair the central nervous system's ability to mount an appropriate response to environmental stressors, heightening the probability of relapse. However, the relationship between stress, relapse, and HPA axis disturbances remains tentative. In the proposed study, the investigators will assess the contribution of trauma, stress, and alcohol use upon pituitary-adrenocortical functioning in alcohol dependence. The relative contribution of adrenocortical disruption and episodic stress to prospective drinking behaviors will then be determined.
Hypothesis: We hypothesize (1) that lifetime trauma, recent stress, and chronic alcohol use will additively contribute to HPA axis disruption, (2) alterations in glucocorticoid and neurosteroid release as well as episodic stress will predict a return to drinking.
Methods: One hundred treatment-seeking, one-month abstinent, alcohol-dependent subjects will be studied. Standardized assessments will be used to assess childhood and adult trauma as well as recent (six months) stress. Pituitary-adrenal (including ACTH, cortisol, and neurosteroids) responses to both neuroendocrine [ovine corticotropin releasing hormone (oCRH), cosyntropin, and dexamethasone] and experiential (public speaking) challenges will be measured. Drinking behavior and episodic stress will be prospectively assessed for six months following neuroendocrine assessment.
Significance: If our hypotheses are supported, a definitive connection between previous trauma, biological stress response mechanisms, and ongoing stress upon prospective drinking behavior will be demonstrated. The identification of a specific biologic mechanism that underlies this association will provide a fertile framework for the development of targeted pharmacological interventions to decrease relapse in this vulnerable population. In addition, elucidating the concurrent contributions of stress-response biologic systems and externals stressors will provide the therapist and patient with a constellation of specific risk factors for focused treatment.
Eligibility| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inpatient treatment facility for substance use disorders.
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Michael F Lay | 214 6456989 | michael.lay@utsouthwestern.edu |
| Contact: Kirsten Gilbert | 214 6455988 | kirsten.gilbert@utsouthwestern.edu |
| United States, Texas | |
| UT Southwestern Medical Center at Dallas | Recruiting |
| Dallas, Texas, United States, 75390-8564 | |
| Contact: Bryon Adinoff, MD 214-645-6975 bryon.adinoff@utsouthwestern.edu | |
| Contact: Michael Lay, BA 214-675-6989 ext 284 michael.lay@utsouthwestern.edu | |
| Principal Investigator: Bryon Adinoff, MD | |
| Principal Investigator: | Bryon Adinoff, MD | UT Southwestern Medical Center at Dallas and VA North Texas Health Care System |
More Information
| Responsible Party: | Bryon Adinoff, MD, Professor, University of Texas Southwestern Medical Center at Dallas |
| ClinicalTrials.gov Identifier: | NCT00744588 History of Changes |
| Other Study ID Numbers: | AA016668, U01-AA016668-02 |
| Study First Received: | June 19, 2008 |
| Last Updated: | August 29, 2008 |
| Health Authority: | United States: Institutional Review Board |
|
substance abuse alcohol dependence hypothalamic-pituitary-adrenal (HPA) system cosyntropin corticotropin-releasing Hormone (CRH) pituitary-adrenal system |
stress trauma neurosteroids cortisol relapse |
|
Alcoholism Alcohol-Related Disorders Substance-Related Disorders Mental Disorders Corticotropin-Releasing Hormone |
Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs Pharmacologic Actions |